Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131
- First Online:
- 187 Downloads
The purpose of this study was twofold: (1) to measure the radiation exposure to family members of out-patients with thyrotoxicosis treated with radioiodine, 131I, using the recommendations from the European Commission (EC) guidance and age-specific periods for behaviour restrictions; (2) to use the results to identify necessary restrictions to ensure recommended dose constraints.
The study population comprised 76 family members (46 adults and 30 children below the age of 18) of 42 patients. The patients were treated with an average activity of 417 MBq (range 260–600 MBq). They received oral and written EC recommendations about behaviour restrictions (translated into Norwegian). On the day of treatment we repeated the oral instructions to the patient and an adult family member. The time periods for restrictions were 14 days for children aged 0–10 years, 7 days for persons aged 11–59 years and 3 days for persons aged 60 years and older. Family members wore a thermoluminescent dosimeter (TLD) on each wrist day and night for 2 weeks. The doses received were adjusted to give an estimate of the expected values if the TLDs had been worn indefinitely.
Radiation doses well below the recommended dose constraints were measured for all adult family members and children, except one 2-year-old child; in the latter case the mother probably did not comply with the instructions given.
The radiation dose to family members of thyrotoxic patients treated with up to 600 MBq of radioiodine is well below recommended dose constraints if EC instructions are given and compliance is adequate. The duration of restrictions for various age groups used in this study may be considered when establishing guidelines in Norway.
KeywordsIodine-131 therapy Thyrotoxicosis Radiation protection Guidelines
- 4.Schomaecker K, Fisher T, Gaidouk, M, Schicha H. Exhalation of 131I after radioiodine therapy: time dependence and chemical form. Proceedings of the 47th annual meeting, Society of Nuclear Medicine (abstract). J Nucl Med 2000;41 Suppl:251PGoogle Scholar
- 6.Council of the European Union. Guideline 96/29/EURATOM to determine basic directions for health protection of public and workers against ionizing radiation related dangers. Leafl Eur Commun 1996;L159/1Google Scholar
- 7.Council of the European Union. Directive on the health protection of individuals against the dangers of ionizing radiation in relation to medical exposures. 97/43/Euratom OJ 1997;L180:22–7Google Scholar
- 8.International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21(1–3)Google Scholar
- 9.European Commission. Radiation protection 97: radiation protection following iodine-131 therapy (exposures due to outpatients or discharged inpatients). Luxembourg, Belgium: Office for Official Publications of the European Communities; 1998Google Scholar
- 12.Thomson WH, Mills AP, Smith NB, Mostafa AB, Notghi A, Harding LK. Radiation doses to patient’s relatives: day and night components and their significance in terms of ICRP 60. Eur J Nucl Med 1993;993 poster nr 697Google Scholar
- 13.Barrington SF, Kettle AG, Mountford PJ, Thomson WH, Batchelor S, Burrell DN, et al. Radiation exposure of patient’s children at home post I-131 administration. Eur J Nucl Med 1995;22:798Google Scholar
- 17.Cappelen T, Unhjem JF. Patients with hyperthyroidism treated with radioactive iodine and exposures to family members. Eur J Nucl Med Mol Imaging 2004;31:P828, S457Google Scholar
- 18.Regulations No. 1362 of 21. November 2003 on Radiation Protection and Use of Radiation (Norwegian Radiation Protection Regulation)Google Scholar